Metabolite

KNApSAcK Entry

id C00026453
Name Kynurenic acid
CAS RN 492-27-3
Standard InChI InChI=1S/C10H7NO3/c12-9-5-8(10(13)14)11-7-4-2-1-3-6(7)9/h1-5H,(H,11,12)(H,13,14)
Standard InChI (Main Layer) InChI=1S/C10H7NO3/c12-9-5-8(10(13)14)11-7-4-2-1-3-6(7)9/h1-5H,(H,11,12)(H,13,14)

Cluster

Phytochemical cluster
KCF-S cluster No. 3907

Link

ChEMBL

By standard InChI CHEMBL299155
By standard InChI Main Layer CHEMBL299155

KEGG

By LinkDB C01717

CTD

By CAS RN D007736

Species

Summary

Plant class

class name count
Spermatophyta 1

Family

family name count
Ephedraceae 1

List (1)

* NCBI
KNApSAcK organism *ID *family *plant class *kingdom
Ephedra pachyclada ssp.sinaica 3387 Ephedraceae Spermatophyta Viridiplantae

Human Protein / Gene in interaction

23 ChEMBL Protein in interactions

accession description class description compound assay ID (# of activities) # of diseases
(OMIM / KEGG)
P10635 Cytochrome P450 2D6 Cytochrome P450 2D6 CHEMBL299155 CHEMBL1741321 (1)
1 / 0
Q9UIF8 Bromodomain adjacent to zinc finger domain protein 2B Unclassified protein CHEMBL299155 CHEMBL1738312 (1)
0 / 0
P10253 Lysosomal alpha-glucosidase Hydrolase CHEMBL299155 CHEMBL1614175 (1)
1 / 1
P11712 Cytochrome P450 2C9 Cytochrome P450 2C9 CHEMBL299155 CHEMBL1741325 (1)
0 / 1
Q9HC97 G-protein coupled receptor 35 Kynurenic acid receptor CHEMBL299155 CHEMBL2038723 (1) CHEMBL2038727 (1)
CHEMBL2038732 (1) CHEMBL2038733 (1)
0 / 0
P00352 Retinal dehydrogenase 1 Enzyme CHEMBL299155 CHEMBL1614458 (1)
0 / 0
O75496 Geminin Unclassified protein CHEMBL299155 CHEMBL2114843 (1)
0 / 0
Q03164 Histone-lysine N-methyltransferase 2A Enzyme CHEMBL299155 CHEMBL1614257 (1) CHEMBL1614410 (1)
CHEMBL1614531 (1)
1 / 3
P83916 Chromobox protein homolog 1 Unclassified protein CHEMBL299155 CHEMBL1738610 (1)
0 / 0
P06280 Alpha-galactosidase A Enzyme CHEMBL299155 CHEMBL1614217 (1)
1 / 1
P08138 Tumor necrosis factor receptor superfamily member 16 Membrane receptor CHEMBL299155 CHEMBL753644 (1)
0 / 0
P28482 Mitogen-activated protein kinase 1 Erk CHEMBL299155 CHEMBL1613808 (1)
0 / 0
P05177 Cytochrome P450 1A2 Cytochrome P450 1A2 CHEMBL299155 CHEMBL1741322 (1)
0 / 0
Q99714 3-hydroxyacyl-CoA dehydrogenase type-2 Enzyme CHEMBL299155 CHEMBL1613910 (1) CHEMBL1614227 (2)
3 / 3
P15428 15-hydroxyprostaglandin dehydrogenase [NAD(+)] Enzyme CHEMBL299155 CHEMBL1614038 (2)
2 / 2
P33261 Cytochrome P450 2C19 Cytochrome P450 2C19 CHEMBL299155 CHEMBL1613777 (1) CHEMBL1741323 (1)
1 / 1
P08684 Cytochrome P450 3A4 Cytochrome P450 3A4 CHEMBL299155 CHEMBL1741324 (1)
0 / 1
O75164 Lysine-specific demethylase 4A Enzyme CHEMBL299155 CHEMBL1737991 (1)
0 / 0
P27695 DNA-(apurinic or apyrimidinic site) lyase Enzyme CHEMBL299155 CHEMBL1614211 (1)
0 / 0
Q9UBT6 DNA polymerase kappa Enzyme CHEMBL299155 CHEMBL1794536 (1)
0 / 0
B2RXH2 Lysine-specific demethylase 4E Enzyme CHEMBL299155 CHEMBL1613914 (3)
0 / 0
Q96KQ7 Histone-lysine N-methyltransferase EHMT2 Enzyme CHEMBL299155 CHEMBL1738442 (2)
0 / 0
O00255 Menin Unclassified protein CHEMBL299155 CHEMBL1614257 (1) CHEMBL1614531 (1)
2 / 5

CTD interaction (16)

compound gene gene name gene description interaction interaction type form reference
pmid
D007736 196 AHR
bHLHe76
aryl hydrocarbon receptor AHR protein affects the reaction [[Kynurenic Acid co-treated with IL1B protein] results in increased expression of CYP1A1 mRNA] affects cotreatment
/ affects reaction
/ increases expression
protein 20106948
D007736 196 AHR
bHLHe76
aryl hydrocarbon receptor AHR protein affects the reaction [[Kynurenic Acid co-treated with IL1B protein] results in increased expression of IL6 mRNA] affects cotreatment
/ affects reaction
/ increases expression
protein 20106948
D007736 196 AHR
bHLHe76
aryl hydrocarbon receptor Kynurenic Acid binds to and results in increased activity of AHR protein affects binding
/ increases activity
protein 20106948
D007736 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) AHR protein affects the reaction [[Kynurenic Acid co-treated with IL1B protein] results in increased expression of CYP1A1 mRNA] affects cotreatment
/ affects reaction
/ increases expression
mRNA 20106948
D007736 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) [Kynurenic Acid co-treated with IL1B protein] results in increased expression of CYP1A1 mRNA affects cotreatment
/ increases expression
mRNA 20106948
D007736 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) Kynurenic Acid results in increased activity of CYP1A1 protein increases activity
protein 20106948
D007736 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) Kynurenic Acid results in increased expression of CYP1A1 mRNA increases expression
mRNA 20106948
D007736 2246 FGF1
AFGF
ECGF
ECGF-beta
ECGFA
ECGFB
FGF-1
FGF-alpha
FGFA
GLIO703
HBGF-1
HBGF1
fibroblast growth factor 1 (acidic) Kynurenic Acid results in decreased secretion of FGF1 protein decreases secretion
protein 16392031
D007736 2859 GPR35
G protein-coupled receptor 35 Kynurenic Acid binds to and results in increased activity of GPR35 protein affects binding
/ increases activity
protein 20826425
D007736 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta AHR protein affects the reaction [[Kynurenic Acid co-treated with IL1B protein] results in increased expression of CYP1A1 mRNA] affects cotreatment
/ affects reaction
/ increases expression
protein 20106948
D007736 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta AHR protein affects the reaction [[Kynurenic Acid co-treated with IL1B protein] results in increased expression of IL6 mRNA] affects cotreatment
/ affects reaction
/ increases expression
protein 20106948
D007736 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta IL1B protein promotes the reaction [Kynurenic Acid results in increased expression of IL6 mRNA] increases expression
/ increases reaction
protein 20106948
D007736 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta [Kynurenic Acid co-treated with IL1B protein] results in increased expression of CYP1A1 mRNA affects cotreatment
/ increases expression
protein 20106948
D007736 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) AHR protein affects the reaction [[Kynurenic Acid co-treated with IL1B protein] results in increased expression of IL6 mRNA] affects cotreatment
/ affects reaction
/ increases expression
mRNA 20106948
D007736 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) IL1B protein promotes the reaction [Kynurenic Acid results in increased expression of IL6 mRNA] increases expression
/ increases reaction
mRNA 20106948
D007736 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) Kynurenic Acid results in increased expression of IL6 mRNA increases expression
mRNA 20106948

Related Disease

Diseases related to proteins in ChEMBL interactions

OMIM (12)

OMIM preferred title UniProt
#300438 17-beta-hydroxysteroid dehydrogenase x deficiency Q99714
#119900 Digital clubbing, isolated congenital P15428
#609535 Drug metabolism, poor, cyp2c19-related P33261
#608902 Drug metabolism, poor, cyp2d6-related P10635
#301500 Fabry disease P06280
#232300 Glycogen storage disease ii P10253
#605130 Hairy elbows, short stature, facial dysmorphism, and developmental delay Q03164
#145000 Hyperparathyroidism 1; hrpt1 O00255
#259100 Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 P15428
#300705 Mental retardation, x-linked 17; mrx17 Q99714
#300220 Mental retardation, x-linked, syndromic 10; mrxs10 Q99714
#131100 Multiple endocrine neoplasia, type i; men1 O00255

KEGG DISEASE (17)

KEGG disease name UniProt
H00033 Adrenal carcinoma O00255 (related)
H00034 Carcinoid O00255 (related)
H00045 Malignant islet cell carcinoma O00255 (related)
H00246 Primary hyperparathyroidism O00255 (related)
H01102 Pituitary adenomas O00255 (related)
H00125 Fabry disease P06280 (related)
H00036 Osteosarcoma P08684 (marker)
H00069 Glycogen storage diseases (GSD) P10253 (related)
H01205 Coumarin resistance P11712 (related)
H00457 Primary hypertrophic osteoarthropathy (PHO) P15428 (related)
H01246 Isolated congenital nail clubbing (ICNC) P15428 (related)
H01171 Poor drug metabolism (PM) P33261 (related)
H00001 Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) Q03164 (related)
Q03164 (marker)
H00002 Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) Q03164 (related)
H00480 Non-syndromic X-linked mental retardation Q99714 (related)
H00658 Syndromic X-linked mental retardation Q99714 (related)
H00925 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency Q99714 (related)

Diseases related to CTD interactions

5 disease from interactions of metabolites

MeSH disease OMIM compound disease name evidence type reference
pmid
D001172 D007736 Arthritis, Rheumatoid marker/mechanism
16220290
D006948 D007736 Hyperkinesis therapeutic
8000442
D006973 D007736 Hypertension marker/mechanism
1436509
D009410 D007736 Nerve Degeneration therapeutic
17539917
D012640 D007736 Seizures therapeutic
7902066
16457470
21620807